Literature DB >> 19138964

Lung cancer risk models come of age.

John K Field1.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 19138964     DOI: 10.1158/1940-6207.CAPR-08-0144

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


× No keyword cloud information.
  5 in total

Review 1.  Lung cancer screening: identifying the high risk cohort.

Authors:  Michael W Marcus; Olaide Y Raji; John K Field
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

2.  The potential for using risk models in future lung cancer screening trials.

Authors:  John K Field; Olaide Y Raji
Journal:  F1000 Med Rep       Date:  2010-05-24

3.  Risk prediction models for lung cancer: Perspectives and dissemination.

Authors:  Wei Tang; Qin Peng; Yanzhang Lyu; Xiaoshuang Feng; Xin Li; Luopei Wei; Ni Li; Hongda Chen; Wanqing Chen; Min Dai; Ning Wu; Jiang Li; Yao Huang
Journal:  Chin J Cancer Res       Date:  2019-04       Impact factor: 5.087

4.  Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma.

Authors:  Abby L Cosentino-Boehm; Jacqueline M Lafky; Tammy M Greenwood; Kimberly D Kimbler; Marites C Buenafe; Yuxia Wang; Adam J Branscum; Ping Yang; Nita J Maihle; Andre T Baron
Journal:  Diagnostics (Basel)       Date:  2013-01-14

5.  Analysis of the Clinicopathologic Characteristics of Lung Adenocarcinoma With CTNNB1 Mutation.

Authors:  Chao Zhou; Wentao Li; Jinchen Shao; Jikai Zhao; Chang Chen
Journal:  Front Genet       Date:  2020-02-07       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.